Subgrouping based on the proportion of PD-L1-positive tumor cells with cutoff values of 5% and 50% revealed that low (1–5%), moderate (5–50%), and high (≥50%) PD-L1 subgroups accounted for 35 (68.6%), 11 (21.6%), and 5 (9.8%) patients, respectively. The gene discussed is CD274; the disease is neoplasm.